TY - JOUR
T1 - Impact of percutaneous intervention compared to pharmaceutical therapy on complex arrhythmias in patients with chronic total coronary occlusion. Rationale and design of the CTO-ARRHYTHMIA study
AU - Christensen, Martin Kirk
AU - Eftekhari, Ashkan
AU - Raungaard, Bent
AU - Steigen, Terje Kristian
AU - Kumsaars, Indulis
AU - Riahi, Sam
AU - Søgaard, Peter
AU - Thuesen, Leif
N1 - Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2023/9
Y1 - 2023/9
N2 - Chronic total coronary occlusions (CTO) occur in up to 50 % of patients with coronary artery disease by angiography. In CTO-patients, clinically significant arrhythmia is potentially important and insufficiently investigated. Therefore, the purpose of the CTO-ARRHYTHMIA study was to investigate the incidence of loop recorder detected clinically significant arrhythmias and the effect on arrhythmias of revascularization by CTO-PCI. The study is an independent sub-study of the NOrdic-Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion (NOBLE-CTO); ClinicalTrials.gov Identifier NCT03392415. NOBLE-CTO prospectively collects procedural data, quality of life measures, echocardiographic and cardiac MRI findings before and after treatment as well as clinical outcomes in all CTO patients that may be treated by PCI.
AB - Chronic total coronary occlusions (CTO) occur in up to 50 % of patients with coronary artery disease by angiography. In CTO-patients, clinically significant arrhythmia is potentially important and insufficiently investigated. Therefore, the purpose of the CTO-ARRHYTHMIA study was to investigate the incidence of loop recorder detected clinically significant arrhythmias and the effect on arrhythmias of revascularization by CTO-PCI. The study is an independent sub-study of the NOrdic-Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion (NOBLE-CTO); ClinicalTrials.gov Identifier NCT03392415. NOBLE-CTO prospectively collects procedural data, quality of life measures, echocardiographic and cardiac MRI findings before and after treatment as well as clinical outcomes in all CTO patients that may be treated by PCI.
KW - Arrhythmias
KW - CTO
KW - Chronic total occlusion
KW - Ventricular tachycardia
UR - http://www.scopus.com/inward/record.url?scp=85153591359&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2023.04.001
DO - 10.1016/j.carrev.2023.04.001
M3 - Journal article
C2 - 37117085
SN - 1553-8389
VL - 54
SP - 69
EP - 72
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
ER -